Cancer Council NSW has announced the appointment of Professor Martin Widschwendter, MD, PhD, FRCOG, as the new Director of the Daffodil Centre, at Cancer Council NSW.
The Daffodil Centre, a partnership between Cancer Council NSW and the University of Sydney, will be led by Professor Widschwendter (pictured), working alongside Professor Anne Cust, University of Sydney Director of the Daffodil Centre.
An internationally recognised pioneer in women’s cancer prevention and a global leader in translational epigenetics, the Cancer Council says Professor Widschwendter will guide the Daffodil Centre into a bold new phase, strengthening NSW’s position as a world leader in precision cancer prevention and advancing cancer research that delivers meaningful, long‑term benefits for communities.
After specialist training in Obstetrics and Gynaecology in Austria, Professor Widschwendter joined the University of Southern California’s Norris Comprehensive Cancer Centre in Los Angeles to train with pioneers in epigenetics. Whilst working as a gynaecological oncology surgeon in 2005, he led the Women’s Cancer Department at University College London (UCL), focusing on the integration of molecular biomarkeers into clinical pathways for breast and gynaecological cancer prevention. Whilst retaining his professorship at UCL, in 2020 he founded the European Translational Oncology Prevention and Screening (EUTOPS) Institute at the University of Innsbruck.
Under Professor Widschwendter’s leadership, the Daffodil Centre will continue to advance policy and drive a strong focus on precision prevention that will change the path of cancer, the organisation said in a statement.
